Table of Content

Chapter 1 About the Ankylosing Spondylitis Industry
1.1 Industry Definition and Types
1.1.1 Disease-modifying anitrheumatic drugs (DMARDs)
1.1.2 Nonsteroidal anti-inflammatory drugs (NSAIDs)
1.1.3 Biologics
1.1.1.4 Other
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape
2.1 Ankylosing Spondylitis Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2019-2024
Sales and Growth Rate 2019-2024
Major Players
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2019-2024
Sales and Growth Rate 2019-2024
Major Players
2.1.3 China
Market Revenue (M USD) and Growth Rate 2019-2024
Sales and Growth Rate 2019-2024
Major Players
2.1.4 India
Market Revenue (M USD) and Growth Rate 2019-2024
Sales and Growth Rate 2019-2024
Major Players
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2019-2024
Sales and Growth Rate 2019-2024
Major Players
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2019-2024
Sales and Growth Rate 2019-2024
Major Players
2.2 World Ankylosing Spondylitis Market by Types
Disease-modifying anitrheumatic drugs (DMARDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Biologics
Other
2.3 World Ankylosing Spondylitis Market by Applications
Ankylosing spondylitis (AS) in adults
Juvenile ankylosing spondylitis (JAS)
Application 3
Application 4
2.4 World Ankylosing Spondylitis Market Analysis
2.4.1 World Ankylosing Spondylitis Market Revenue and Growth Rate 2019-2024
2.4.2 World Ankylosing Spondylitis Market Consumption and Growth rate 2019-2024
2.4.3 World Ankylosing Spondylitis Market Price Analysis 2019-2024

Chapter 3 World Ankylosing Spondylitis Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2024, Through 2029
3.4 Major Revenue (M USD) Market share By Regions in 2024, Through 2029

Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2019-2024
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis

Chapter 5 Company Profiles
5.1 Abbvie
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 Amgen
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 Merck & Co.
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 Boehringer Ingelheim
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Celgene
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Celltrion
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Eisai
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 F. Hoffmann-La Roche
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 Novartis
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Janssen Pharmaceuticals
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Regeneron Pharmaceuticals
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Sanofi
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 UCB
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits
5.14 Xian janssen
5.14.1 Company Details (Foundation Year, Employee Strength and etc)
5.14.2 Product Information (Picture, Specifications and Applications)
5.14.3 Revenue (M USD), Price and Operating Profits
5.15 Celgen Biopharma
5.15.1 Company Details (Foundation Year, Employee Strength and etc)
5.15.2 Product Information (Picture, Specifications and Applications)
5.15.3 Revenue (M USD), Price and Operating Profits

Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry

Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India

Chapter 9 World Ankylosing Spondylitis Market Forecast through 2029
9.1 World Ankylosing Spondylitis Demand by Regions Forecast through 2029
9.2 World Ankylosing Spondylitis Price(by Regions, Types, Applications)Analysis Forecast through 2029
9.3 World Ankylosing Spondylitis Revenue (M USD)(by Regions, Types, Applications) Forecast through 2029
9.4 World Ankylosing Spondylitis Market Analysis
9.4.1 World Ankylosing Spondylitis Market Revenue and Growth Rate 2019-2024
9.4.2 World Ankylosing Spondylitis Market Consumption and Growth rate 2019-2024
9.4.3 World Ankylosing Spondylitis Market Price Analysis 2019-2024

Chapter 10 Key success factors and Market Overview

Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2019-2024
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2019-2024
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2019-2024
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2019-2024
Table Major Players
Table Market Revenue (M USD) and Growth Rate 2019-2024
Table Major Players
Table Major Production Market share by Players 2024
Table Major Revenue (M USD) Market share by Players 2024
Table Production Market share by Major Regions in 2019-2024
Table Production Market share by Major Regions in 2024-2029
Table Revenue (M USD) Market share by Regions in 2019-2024
Table Revenue (M USD) Market share by Regions in 2024-2029
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2019-2024
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Abbvie Information List
Figure Ankylosing SpondylitisAnkylosing Spondylitis Picture, Specifications and Applications of Abbvie
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Abbvie 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Abbvie 2023-2024
Table Amgen Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Amgen
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Amgen 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Amgen 2023-2024
Table Merck & Co. Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Merck & Co.
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Merck & Co. 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Merck & Co. 2023-2024
Table Boehringer Ingelheim Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Boehringer Ingelheim
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Boehringer Ingelheim 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Boehringer Ingelheim 2023-2024
Table Celgene Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Celgene
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Celgene 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Celgene 2023-2024
Table Celltrion Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Celltrion
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Celltrion 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Celltrion 2023-2024
Table Eisai Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Eisai
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Eisai 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Eisai 2023-2024
Table F. Hoffmann-La Roche Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of F. Hoffmann-La Roche
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of F. Hoffmann-La Roche 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of F. Hoffmann-La Roche 2023-2024
Table Novartis Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Novartis
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Novartis 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Novartis 2023-2024
Table Janssen Pharmaceuticals Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Janssen Pharmaceuticals
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Janssen Pharmaceuticals 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Janssen Pharmaceuticals 2023-2024
Table Regeneron Pharmaceuticals Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Regeneron Pharmaceuticals
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Regeneron Pharmaceuticals 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Regeneron Pharmaceuticals 2023-2024
Table Sanofi Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Sanofi
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Sanofi 2023-2024
Table UCB Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of UCB
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of UCB 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of UCB 2023-2024
Table Xian janssen Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Xian janssen
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Xian janssen 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Xian janssen 2023-2024
Table Celgen Biopharma Information List
Figure Ankylosing Spondylitis Picture, Specifications and Applications of Celgen Biopharma
Table Ankylosing Spondylitis Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Celgen Biopharma 2023-2024
Figure Ankylosing Spondylitis Sales Volume and World Market Share of Celgen Biopharma 2023-2024
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Ankylosing Spondylitis (2024-2029)
Table World Price by Regions Forecast Analysis of Ankylosing Spondylitis (2024-2029)
Table World Price by Types Forecast Analysis of Ankylosing Spondylitis (2024-2029)
Table World Price by Applications Forecast Analysis of Ankylosing Spondylitis (2024-2029)
Table World Revenue (M USD) by Regions Forecast Analysis of Ankylosing Spondylitis (2024-2029)
Table World Revenue (M USD) by Types Forecast Analysis of Ankylosing Spondylitis (2024-2029)
Table World Revenue (M USD) by Applications Forecast Analysis of Ankylosing Spondylitis (2024-2029)